skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

ファーマインテリジェンスはInforma PLCのインフォーマインテリジェンス部門の一部です

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon レポートストアメルマガ登録製品ログインProductLogin
Global Search Configuration
  • Close Icon

About Bridget

Washington DC, USA

+26 year(s) experience

Bridget Silverman has been covering FDA for the Pink Sheet since David Kessler was commissioner, with a focus on the US drug review and approval process. She oversees the FDA Performance Tracker suite of interactive charts and the Drug Review Profile series of deep dives into FDA review decisions.
Bridget is especially interested in how regulatory reforms and policy initiatives affect clinical trial design and R&D strategy. She covered the commercial and financial beats for the Pink Sheet before focusing on drug development as an editor on Pharmaceutical Approvals Monthly and the NDA Pipeline, where she helped to develop database products that inform our current regulatory tracking features. In her down time, Bridget reads mystery novels and keeps track of her family and three dogs.

Specialties

  • Biopharma Pipeline Strategy
  • Policy & Regulation
  • Clinical Trial Strategy
  • Clinical Trials
  • Drug Development

Bridget Writes For

Analyst Articles

Articles by Ian